Advertisement
Zur Diskussion| Volume 108, ISSUE 10, P601-603, 2014

Download started.

Ok

When Choosing Wisely meets clinical practice guidelines

DOI:https://doi.org/10.1016/j.zefq.2014.10.014
When Choosing Wisely meets clinical practice guidelines
Previous ArticleNeue Kurzinformation erschienen: Dauerhaft starke Schmerzen – wann helfen Opioide?
Next ArticleEbola – contradictions between knowledge and communication

      Summary

      The American Board of Internal Medicine (ABIM) Foundation launched the Choosing Wisely campaign in 2012 and until today convinced more than 50 US specialist societies to develop lists of interventions that may not improve people's health but are potentially harmful. We suggest combining these new efforts with the already existing efforts in clinical practice guideline development. Existing clinical practice guidelines facilitate a more participatory and evidence-based approach to the development of top 5 lists. In return, adding top 5 lists (for overuse and underuse) to existing clinical practice guidelines nicely addresses a neglected dimension to clinical practice guideline development, namely explicit information on which Do or Don’t do recommendations are frequently disregarded in practice.

      Zusammenfassung

      Die American Board of Internal Medicine (ABIM) Foundation hat im Jahr 2012 die sogenannte Choosing-Wisely-Kampagne gestartet. Diese Kampagne überzeugte bis heute über 50 US-amerikanische Fachgesellschaften davon, sogenannte Top-5-Listen zu erstellen. Top-5-Listen präsentieren medizinische Maßnahmen, die dem Patienten nicht nützen, sondern sogar schädlich für die Gesundheit sein können. In diesem Beitrag wird vorgestellt, wie die Entwicklung von Top-5-Listen evidenzbasierter und partizipatorischer werden kann, indem sie in ein bestehendes Leitlinienprogramm integriert wird. Im Gegenzug bieten entsprechende Top-5-Listen eine Möglichkeit, die bislang in der Leitlinienentwicklung vernachlässigten Aspekte von Über- und Unterversorgung explizit zu adressieren. So könnten Top-5-Listen aufzeigen, welche „Tun“- oder „Lassen“-Leitlinienempfehlungen in der Praxis häufig nicht berücksichtigt werden.

      Keywords

      Schlüsselwörter

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

      1. German Network of Evidence based Medicine (DNEbM). Website for current discussions on a Choosing Wisely initative in Germany [German language]. 2014. http://www.ebm-netzwerk.de/was-wir-tun/themenportale/gemeinsam-klug-entscheiden/ziel-inhalt.

        View in Article

      2. ABIM Foundation. http://www.choosingwisely.org/.

        View in Article

      3. Choosing Wisely Canada. http://www.choosingwiselycanada.org/.

        View in Article
        • Hurley R.
        Can doctors reduce harmful medical overuse worldwide?.
        BMJ. 2014; 349 ([published Online First: Epub Date]|): g4289https://doi.org/10.1136/bmj.g4289
        View in Article
        • Qaseem A.
        • Forland F.
        • Macbeth F.
        • et al.
        Guidelines International Network: toward international standards for clinical practice guidelines.
        Ann Intern Med. 2012; 156 ([published Online First: Epub Date]|): 525-531https://doi.org/10.7326/0003-4819-156-7-201204030-00009
        View in Article

      6. Standing Guideline Commission of the Association of Scientific Medical Societies in Germany (AWMF). AWMF Guidance Manual and Rules for Guideline Development. 2012. http://www.awmf.org/fileadmin/user_upload/Leitlinien/AWMF-Regelwerk/AWMF-Guidance_2013.pdf.

        View in Article

      7. National Programme for Disease Management Guidelines. National Disease Management Guideline. Low back pain. Short Version. 2011. http://www.versorgungsleitlinien.de/themen/kreuzschmerz/pdf/nvl-kreuzschmerz-kurz-engl-4.pdf.

        View in Article

      8. Agency for Quality in Medicine (ÄZQ). National Disease Management Guidelines. Quality Indicators. A Manual for Authors. Short Version. 2010. http://www.aezq.de/mdb/edocs/pdf/schriftenreihe/schriftenreihe36-englisch-short.pdf.

        View in Article

      9. German Guideline Program in Oncology (GGPO). Development of guideline based quality indicators. Methods paper for the German Guideline Program in Oncology. 2013. http://leitlinienprogramm-onkologie.de/uploads/tx_sbdownloader/QIDP_GGPO_2013.pdf.

        View in Article

      Article info

      Identification

      DOI: https://doi.org/10.1016/j.zefq.2014.10.014

      Copyright

      © 2014 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX